Long-term bortezomib treatment reduces allergen-specific IgE but fails to ameliorate chronic asthma in mice

International Archives of Allergy and Immunology

Volumn 158, Issue 1, 2012, Pages 43-53

  Wegmann, Michael ^a   Lunding, Lars ^a   Orinska, Zane ^a   Wong, David M ^b   Manz, Rudolf A ^b   Fehrenbach, Heinz ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Allergic asthma; Animal models; B lymphocytes; Immunoglobulin E; Inhibition of inflammation; Therapy

Indexed keywords

ALLERGEN; BORTEZOMIB; IMMUNOGLOBULIN E; OVALBUMIN;

AEROSOL; ALLERGIC ASTHMA; ALLERGIC BRONCHIAL ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HISTOPATHOLOGY; LUNG FUNCTION; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIZATION; TITRIMETRY;

ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BORONIC ACIDS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LUNG; MICE; MICE, INBRED BALB C; PLASMA CELLS; PYRAZINES; TREATMENT FAILURE;

EID: 84855168263     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000330103     Document Type: Article

References (34)

1. Broide D: New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007. J Allergy Clin Immunol 2008; 122: 475-480.
2. Matsumoto K, Tamari M, Saito H: Involvement of eosinophils in the onset of asthma. J Allergy Clin Immunol 2008; 121: 26-27.
3. Fanta CH: Asthma. N Engl J Med 2009; 360: 1002-1014.
4. Luger EO, Wegmann M, Achatz G, Worm M, Renz H, Radbruch A: Allergy for a lifetime? Allergol Int 2010; 59: 1-8.
5. Teicher BA, Ara G, Herbst R, Palombella VJ, Adams J: The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res 1999; 5: 2638-2645. (Pubitemid 29437352)
6. Meister S, Schubert U, Neubert K, Herrmann K, Burger R, Gramatzki M, Hahn S, Schreiber S, Wilhelm S, Herrmann M, Jäck HM, Voll RE: Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Cancer Res 2007; 67: 1783-1792. (Pubitemid 46383406)
7. Katodritou E, Kartsios C, Gastari V, Verrou E, Mihou D, Banti A, Lazaraki G, Lazaridou A, Kaloutsi V, Zervas K: Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: First reported case. Leuk Res 2008; 32: 339-341. (Pubitemid 351222674)
8. Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, Voll RE: The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 2008; 14: 748-755. (Pubitemid 351951516)
9. Wegmann M, Fehrenbach H, Fehrenbach A, Held T, Schramm C, Garn H, Renz H: Involvement of distal airways in a chronic model of experimental asthma. Clin Exp Allergy 2005; 35: 1263-1271.
10. Mehlhop PD, van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, Oettgen HC: Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997; 94: 1344-1349. (Pubitemid 27087853)
11. Luger EO, Fokuhl V, Wegmann M, Abram M, Tillack K, Achatz G, Manz RA, Worm M, Radbruch A, Renz H: Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. J Allergy Clin Immunol 2009; 124: 819-826.
12. Abram M, Wegmann M, Fokuhl V, Sonar S, Luger EO, Kerzel S, Radbruch A, Renz H, Zemlin M: Nerve growth factor and neurotrophin-3 mediate survival of pulmonary plasma cells during the allergic airway inflammation. J Immunol 2009; 182: 4705-4712.
13. Wegmann M, Göggel R, Sel S, Sel S, Erb KJ, Kalkbrenner F, Renz H, Garn H: Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. Am J Respir Cell Mol Biol 2007; 36: 61-67. (Pubitemid 46067708)
14. Lonial S, Waller EK, Richardson PG, Jagannath S, Orlowski RZ, Giver CR, Jaye DL, Francis D, Giusti S, Torre C, Barlogie B, Berenson JR, Singhal S, Schenkein DP, Esseltine DL, Anderson J, Xiao H, Heffner LT, Anderson KC; SUMMIT/CREST Investigators: Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma. Blood 2005; 106: 3777-3784. (Pubitemid 41739012)
15. Sel S, Wegmann M, Sel S, Bauer S, Garn H, Alber G, Renz H: Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J Immunol 2007; 178: 7805-7813. (Pubitemid 46898052)
16. Sel S, Wegmann M, Dicke T, Sel S, Henke W, Yildirim AO, Renz H, Garn H: Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. J Allergy Clin Immunol 2008; 121: 910-916.
17. Orinska Z, Osiak A, Löhler J, Bulanova E, Budagian V, Horak I, Bulfone-Paus S: Novel B cell population producing functional IgG in the absence of membrane IgM expression. Eur J Immunol 2002; 32: 3472-3480. (Pubitemid 36024385)
18. Fulkerson PC, Rothenberg ME, Hogan SP: Building a better mouse model: Experimental models of chronic asthma. Clin Exp Allergy 2005; 35: 1251-1253.
19. Hershko A: Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol 1997; 9: 788-799. (Pubitemid 27517267)
20. van der Vlag J, Berden JH: Proteasome inhibition: A new therapeutic option in lupus nephritis? Nephrol Dial Transplant 2008; 23: 3771-3772.
21. Vieira P, Rajewsky K: The half-lives of serum immunoglobulins in adult mice. Eur J Immunol 1988; 18: 313-316. (Pubitemid 18078861)
22. Dubey S, Schiller JH: Three emerging new drugs for NSCLC: Pemetrexed, bortezomib, and cetuximab. Oncologist 2005; 10: 282-291. (Pubitemid 40559593)
23. Herz U, Lumpp U, Daser A, Gelfand EW, Renz H: Murine animal models to study the central role of T cells in immediate-type hypersensitivity responses. Adv Exp Med Biol 1996; 409: 25-32.
24. Lee SW, Kim JH, Park YB, Lee SK: Bortezomib attenuates murine collagen-induced arthritis. Ann Rheum Dis 2009; 68: 1761-1767.
25. Schiff D, Wen PY, van den Bent MJ: Neurological adverse effects caused by cytotoxic and targeted therapies. Nat Rev Clin Oncol 2009; 6: 596-603.
26. Argyriou AA, Iconomou G, Kalofonos HP: Bortezomib-induced peripheral neuropathy in multiple myeloma: A comprehensive review of the literature. Blood 2008; 112: 1593-1599.
27. Theofilopoulos AN, Dixon FJ: Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269-390. (Pubitemid 15093080)
28. Henderson WR Jr., Chiang GK, Tien YT, Chi EY: Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 2006; 173: 718-728.
29. López E, del Pozo V, Miguel T, Sastre B, Seoane C, Civantos E, Llanes E, Baeza ML, Palomino P, Cárdaba B, Gallardo S, Manzarbeitia F, Zubeldia JM, Lahoz C: Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. J Immunol 2006; 176: 1943-1950. (Pubitemid 43134340)
30. Munitz A, Bachelet I, Levi-Schaffer F: Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 2006; 118: 1082-1089. (Pubitemid 44666985)
31. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC: A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003; 348: 2609-2617. (Pubitemid 36741588)
32. Oerlemans R, Franke NE, Assaraf YG, Cloos J, van Zantwijk I, Berkers CR, Scheffer GL, Debipersad K, Vojtekova K, Lemos C, van der Heijden JW, Ylstra B, Peters GJ, Kaspers GL, Dijkmans BA, Scheper RJ, Jansen G: Molecular basis of bortezomib resistance: Proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood 2008; 112: 2489-2499.
33. Bates JH, Rincon M, Irvin CG: Animal models of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 297:L401-L410.
34. Rokudai A, Terui Y, Kuniyoshi R, Mishima Y, Mishima Y, Aizu-Yokota E, Sonoda Y, Kasahara T, Hatake K: Differential regulation of eotaxin-1/CCL11 and eotaxin-3/ CCL26 production by the TNF-alpha and IL-4 stimulated human lung fibroblast. Biol Pharm Bull 2006; 29: 1102-1109. (Pubitemid 43845467)